Pieris Pharmaceuticals Inc (OQ:PIRS)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for PIRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
May 16/18 May 15/18 Geraghty James A Direct Ownership Common Stock P - Open market or private purchase 10,000 $5.75
May 2/18 Apr 30/18 Orbimed Advisors Llc Indirect Ownership Common Stock S - Open market or private sale -10,400 $6.35
May 2/18 Apr 30/18 Orbimed Advisors Llc Indirect Ownership Common Stock S - Open market or private sale -989,600 $6.35
Apr 26/18 Apr 25/18 Richman Michael Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,665 $4.10
Apr 26/18 Apr 25/18 Barbier Ann Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 30,000  
Feb 26/18 Feb 20/18 Matis Louis Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Feb 26/18 Feb 20/18 Reine Allan Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Feb 26/18 Feb 20/18 Reine Allan Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 53,833  
Feb 26/18 Feb 20/18 Yoder Stephen S. Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 325,000  
Feb 15/18 Feb 13/18 Orbimed Advisors Llc Indirect Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,765  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for PIRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
May 16/18 May 15/18 Geraghty James A Direct Ownership Common Stock P - Open market or private purchase 10,000 $5.75
May 2/18 Apr 30/18 Orbimed Advisors Llc Indirect Ownership Common Stock S - Open market or private sale -10,400 $6.35
May 2/18 Apr 30/18 Orbimed Advisors Llc Indirect Ownership Common Stock S - Open market or private sale -989,600 $6.35
Apr 26/18 Apr 25/18 Richman Michael Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,665 $4.10
Apr 26/18 Apr 25/18 Barbier Ann Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 30,000  
Feb 26/18 Feb 20/18 Matis Louis Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Feb 26/18 Feb 20/18 Reine Allan Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 50,000  
Feb 26/18 Feb 20/18 Reine Allan Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 53,833  
Feb 26/18 Feb 20/18 Yoder Stephen S. Direct Ownership Stock Options (Right to buy) A - Grant, award or other under Rule 16b-3(d) 325,000  
Feb 15/18 Feb 13/18 Orbimed Advisors Llc Indirect Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,765  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $PIRS

StockTwits